Key Market Indicators
Czech Pharmaceutical Production is projected to decline slightly over the next five years, reaching approximately €136 million by 2028. This marks a fall from the €138 million recorded in 2023, translating to a 0.3% year-on-year decline in compound annual growth rate (CAGR). Since 2014, Czech pharmaceutical supply has seen a stagnant trend, maintaining a 0% year-on-year change. In the current year, the Czech Republic ranks 14th globally in pharmaceutical production. Hungary has recently surpassed the Czech Republic in this sector, matching its 2023 production value of €138 million. Italy, Spain, and Austria hold the second, third, and fourth spots, respectively, in this ranking.
